Document is current
Any future updates will be listed below
-
Authors
Chi, Sheng-Chu
Hwang, De-Kuang
Chen, Shih-Jen
Weng, Chang-Chi
Huang, Yi Ming
Chou, Yu-Bai
Lin, Tai-Chi
-
Funding
Funding for this research was provided by:
Yun-Sun Ophthalmology Education Research Foundation
Yen Tjing Ling Medical Foundation ((CI-113-26))
Taipei Veterans General Hospital (V114C-191)
- License Information
-
More Information
Article History
Received: 27 June 2025
Accepted: 17 April 2026
First Online: 23 April 2026
Declarations
:
: The study design obtained approval from the Institutional Review Board of Taipei Veterans General Hospital, and all study procedures adhered to the principles outlined in the Declaration of Helsinki. The requirement for informed consent for participation in this retrospective analysis was waived by the Institutional Review Board of Taipei Veterans General Hospital due to the retrospective nature of the study using anonymized chart data. Written informed consent for the intravitreal injection of aflibercept 8 mg was obtained from all patients prior to treatment as part of routine clinical practice.
: Not required.
: CCW: consultant of Bayer and Novartis/ SJC: consultant of Roche, Bayer, receive travel grant and lecture fee from Novartis, Abbvie/DKH: consultant of Roche, Bayer, Novartis, Abbvie.
